These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36329776)

  • 41. Differences in saccade dynamics between spinocerebellar ataxia 2 and late-onset cerebellar ataxias.
    Federighi P; Cevenini G; Dotti MT; Rosini F; Pretegiani E; Federico A; Rufa A
    Brain; 2011 Mar; 134(Pt 3):879-91. PubMed ID: 21354979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Video game-based coordinative training improves ataxia in children with degenerative ataxia.
    Ilg W; Schatton C; Schicks J; Giese MA; Schöls L; Synofzik M
    Neurology; 2012 Nov; 79(20):2056-60. PubMed ID: 23115212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improvement of balance in progressive degenerative cerebellar ataxias after Ayurvedic therapy: a preliminary report.
    Sriranjini SJ; Pal PK; Devidas KV; Ganpathy S
    Neurol India; 2009; 57(2):166-71. PubMed ID: 19439847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spinocerebellar ataxias.
    Soong BW; Morrison PJ
    Handb Clin Neurol; 2018; 155():143-174. PubMed ID: 29891056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial.
    Coarelli G; Heinzmann A; Ewenczyk C; Fischer C; Chupin M; Monin ML; Hurmic H; Calvas F; Calvas P; Goizet C; Thobois S; Anheim M; Nguyen K; Devos D; Verny C; Ricigliano VAG; Mangin JF; Brice A; Tezenas du Montcel S; Durr A
    Lancet Neurol; 2022 Mar; 21(3):225-233. PubMed ID: 35063116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spinocerebellar ataxia: relationship between phenotype and genotype - a review.
    Sun YM; Lu C; Wu ZY
    Clin Genet; 2016 Oct; 90(4):305-14. PubMed ID: 27220866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of gait and balance impairment in people with spinocerebellar ataxia using wearable sensors.
    Zhou H; Nguyen H; Enriquez A; Morsy L; Curtis M; Piser T; Kenney C; Stephen CD; Gupta AS; Schmahmann JD; Vaziri A
    Neurol Sci; 2022 Apr; 43(4):2589-2599. PubMed ID: 34664180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.
    Feil K; Adrion C; Teufel J; Bösch S; Claassen J; Giordano I; Hengel H; Jacobi H; Klockgether T; Klopstock T; Nachbauer W; Schöls L; Stendel C; Uslar E; van de Warrenburg B; Berger I; Naumann I; Bayer O; Müller HH; Mansmann U; Strupp M
    BMC Neurol; 2017 Jan; 17(1):7. PubMed ID: 28068987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative susceptibility mapping reveals alterations of dentate nuclei in common types of degenerative cerebellar ataxias.
    Deistung A; Jäschke D; Draganova R; Pfaffenrot V; Hulst T; Steiner KM; Thieme A; Giordano IA; Klockgether T; Tunc S; Münchau A; Minnerop M; Göricke SL; Reichenbach JR; Timmann D
    Brain Commun; 2022; 4(1):fcab306. PubMed ID: 35291442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genes implicated in the pathogenesis of spinocerebellar ataxias.
    Wüllner U
    Drugs Today (Barc); 2003 Dec; 39(12):927-37. PubMed ID: 14747838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37.
    Corral-Juan M; Serrano-Munuera C; Rábano A; Cota-González D; Segarra-Roca A; Ispierto L; Cano-Orgaz AT; Adarmes AD; Méndez-Del-Barrio C; Jesús S; Mir P; Volpini V; Alvarez-Ramo R; Sánchez I; Matilla-Dueñas A
    Brain; 2018 Jul; 141(7):1981-1997. PubMed ID: 29939198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The clinical diagnosis of autosomal dominant spinocerebellar ataxias.
    Klockgether T
    Cerebellum; 2008; 7(2):101-5. PubMed ID: 18418679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Real-Life Turning Movements Capture Subtle Longitudinal and Preataxic Changes in Cerebellar Ataxia.
    Thierfelder A; Seemann J; John N; Harmuth F; Giese M; Schüle R; Schöls L; Timmann D; Synofzik M; Ilg W
    Mov Disord; 2022 May; 37(5):1047-1058. PubMed ID: 35067979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in standing stability with balance-based torso-weighting with cerebellar ataxia: A pilot study.
    Widener GL; Conley N; Whiteford S; Gee J; Harrell A; Gibson-Horn C; Block V; Allen DD
    Physiother Res Int; 2020 Jan; 25(1):e1814. PubMed ID: 31749254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dilemma of multiple system atrophy and spinocerebellar ataxias.
    Li M; Ma Q; Zhao X; Wang C; Wu H; Li J; Yang W
    J Neurol; 2018 Dec; 265(12):2764-2772. PubMed ID: 29700645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The assessment and treatment of postural disorders in cerebellar ataxia: a systematic review.
    Marquer A; Barbieri G; Pérennou D
    Ann Phys Rehabil Med; 2014 Mar; 57(2):67-78. PubMed ID: 24582474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Uses of the postural stability test for differential diagnosis of hereditary ataxias.
    Schwabova J; Zahalka F; Komarek V; Maly T; Hrasky P; Gryc T; Cakrt O; Zumrova A
    J Neurol Sci; 2012 May; 316(1-2):79-85. PubMed ID: 22336696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An integrated therapy approach for the management of obesity-associated disorders: A case report.
    Verma A; Shete SU; Doddoli G
    J Family Med Prim Care; 2019 Apr; 8(4):1491-1494. PubMed ID: 31143747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The interrelationship between disease severity, dynamic stability, and falls in cerebellar ataxia.
    Schniepp R; Schlick C; Pradhan C; Dieterich M; Brandt T; Jahn K; Wuehr M
    J Neurol; 2016 Jul; 263(7):1409-17. PubMed ID: 27159995
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
    Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY
    Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.